medical guideline

首页 肿瘤学指南 骨髓瘤 详情

Treatment of Relapsed and Refractory Multiple Myeloma: Recommendations from the International Myeloma Working Group

原文:2021年 发布于 Lancet Oncol 22卷 第3期 e105-e118 浏览量:431 原文链接

作者: International Myeloma Working Group

归属分类: 所属人体系统: 循环 | 分类: 骨髓瘤

关键词: Multiple Myeloma Treatment Guideline


This Policy Review presents the International Myeloma Working Group's clinical practice recommendations for the treatment of relapsed and refractory multiple myeloma. Based on the results of phase 2 and phase 3 trials, these recommendations are proposed for the treatment of patients with relapsed and refractory disease who have received one previous line of therapy, and for patients with relapsed and refractory multiple myeloma who have received two or more previous lines of therapy. These recommendations integrate the issue of drug access in both low-income and middle-income countries and in high-income countries to help guide real-world practice and thus improve patient outcomes.